Investors

Overview

Corporate Profile

Gamida Cell is an advanced cell therapy company committed to finding cures for patients with blood cancers and serious blood diseases. We harness our cell expansion platform to create therapies with the potential to redefine standards of care in areas of serious medical need.

Data Provided by Refinitiv. Minimum 15 minutes delayed.

Latest News

View All
Jul 07, 2020

Gamida Cell Announces Appointment of David Fox to Its Board of Directors

Read More
Jun 12, 2020

Gamida Cell to Present at the JMP Securities Virtual Hematology and Oncology Forum

Read More
May 26, 2020

Gamida Cell Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares

Read More
May 21, 2020

Gamida Cell Reports First Quarter 2020 Financial Results and Provides Company Update

Read More
May 18, 2020

Gamida Cell Announces Pricing of $60 Million Public Offering of Ordinary Shares

Read More
May 18, 2020

Gamida Cell Announces Launch of Proposed Public Offering of Ordinary Shares

Read More
May 18, 2020

Gamida Cell Announces the Date of Its First Quarter 2020 Financial Results and Webcast

Read More
May 12, 2020

Gamida Cell Announces Positive Topline Data from Phase 3 Clinical Study of Omidubicel in Patients with High-Risk Hematologic Malignancies

Read More
Mar 02, 2020

Gamida Cell Announces Updated Data from Phase 1 Study of GDA-201 to be Presented at the Annual Meeting of the European Society for Blood and Marrow Transplantation

Read More
Feb 25, 2020

Gamida Cell Reports Full Year 2019 Financial Results and Provides Company Update

Read More
Feb 19, 2020

Gamida Cell Announces the Date of Its Full Year 2019 Financial Results and Webcast

Read More
Jan 13, 2020

Gamida Cell Announces 2020 Goals and Provides Company Update

Read More
Jan 02, 2020

Gamida Cell Announces Completion of Patient Enrollment in Ongoing Phase 3 Clinical Study of Omidubicel

Read More
Dec 09, 2019

Gamida Cell Announces Results from Phase 1 Study of GDA-201 and New Mechanism of Action Data at ASH 2019 Annual Meeting

Read More
Nov 21, 2019

Gamida Cell to Present at the 31st Annual Piper Jaffray Healthcare Conference

Read More
Nov 13, 2019

Gamida Cell Reports Third Quarter 2019 Financial Results and Provides Company Update

Read More
Nov 06, 2019

Gamida Cell Announces Data to be Presented at ASH 2019 Annual Meeting

Read More
Nov 05, 2019

Gamida Cell Announces the Date of Its Third Quarter 2019 Financial Results and Webcast

Read More
Sep 11, 2019

Gamida Cell and the CIBMTR Announce Collaboration to Advance Research for Life-Saving Cellular Therapy

Read More
Aug 06, 2019

Gamida Cell Reports Second Quarter 2019 Financial Results and Provides Company Update

Read More
Upcoming Events
More events are coming soon.
Corporate Fact Sheet
Corporate Presentation

Investor & Media Contact

Jaren Irene Madden
Vice President of Investor Relations and Corporate Communications
Gamida Cell Ltd.
IRPR@gamida-cell.com